Eurofarma Innovation and Growth Strategy

12 12 GEOGRAPHIC CAPILLARITY Increase in Results Brazil Operations Net Revenue (R$ million) 85% 84% +11% EBITDA and Margin² (R$ million) 29% 27% +21% Pharma Total Market¹ US$ bi (Retail + Non-retail) 44% 56% 54.3 3,218 Brazil LatAm (ex-Brazil) 2,901 941 779 1H21 1H22 % Consolidated Net Revenue 1- IQVIA, excluding Covid-19 vaccines / 2- Adjusted and management data 1H21 EBITDA Margin 1H22 %% consoldated net revenue (1H22) Production Facilities eurofarma Brazil 84%

View entire presentation